A graduate of the First Pavlov State Medical University of St. Petersburg Mikhail Blagosklonny is a professor of Oncology at Roswell Park Center Institute. Mikhail is now a successful scientist who studies cancer and aging after acquiring a Ph.D. in Cardiology and Experimental Medicine from the same institution.
In 2002, Mikhail was appointed associate professor of medicine at the New York Medical College, after which he undertook the role the senior scientist at Ordway Research Institute. Blagosklonny joined Roswell Park Center Institute in 2009 where he was appointed professor of Oncology after having gained much experience and skills from the various places he had previously worked. His research interests include cancer, targeted cancer therapies that protect normal cells from damage, Biogerontology (underlying mechanisms of aging), and anti-aging drugs.
Being a member of cell death and editorial board, Mikhail Blagosklonny has come up with a hypothesis about the possible function of TOR signaling in cancer and aging. He passionately advocates for the use of Rapamycin, a popular drug used in the treatment of cancer, and suggests this as a possible treatment for life extension. The scientist’s research, which ranges from clinical investigations to molecular and cellular biology, mainly involves anticancer therapeutics and cell cycle, signal transduction, drug resistance for normal cells, apoptosis, ontogenesis, and tumor suppressors. Visit ResearchGate.Net to know more about Mikhail’s latest work.
Blagosklonny is also an author of aging hyperfunction theory, and he also writes about chemotherapeutic engineering and cell cyclotherapy. He has successfully managed to have over 300 research articles, reviews and book chapters published under his name. In addition, he is the associate editor of Cancer Biology & Therapy, PLOS ONE, the American Journal of Pathology, and International Journal of Cancer.
Known for his unwavering interest in Oncology, Mikhail’s has a strong belief that it is possible to control cancer and aging. He also believes that once proper use of Rapamycin has been established, cancer can be cured. Mikhail has also come up with various theories that try to explain the aging phenomenon, and believes that in due time and with proper research, scientists will be able to develop a pill against aging. He has given hope to the diseases and natural conditions that seem impossible to cure or change. View Mikhail’s profile on Loop